- Policy, pricing and market access
- Capital, competition and the patent cliff
- AI in pharma: from promise to productivity
- R&D productivity and clinical trial transformation
- Dealmaking, IPOs and biotech funding
- Global competition for science, talent and innovation
US Pharma and Biotech Summit
As policy, pricing, technology and capital markets transform the US healthcare landscape, pharma and biotech leaders face urgent questions about growth, investment and innovation.
The US Pharma and Biotech Summit 2027 will gather the industry’s most senior decision-makers to examine where the next opportunities lie, from AI-enabled R&D and clinical trial redesign to market access, M&A, patient engagement and global competitiveness.
.jpg)
Why Attend?
Learn
how America's life sciences landscape is evolving in areas such as innovation, commercialization and regulation
Engage
with C-suite executives responsible for the big decisions in areas such as funding, workforce development and strategic partnerships
Enjoy
the opportunity to network with peers and build relationships in a friendly but focused environment
Key themes
I really enjoyed CEO insights. When you know what they are thinking we can design our strategies accordingly.
Vice President, Pfizer
THE SUPER EARLY BIRD
IN-PERSON PASS
Gain access to in-person sessions and networking drinks. Network and connect with your peers.
$1,919
plus VAT
THE SUPER EARLY BIRD
DIGITAL PASS
Access to live talks, Q&A and video on demand. Join from the comfort of your home or office.
£239
plus VAT
Speaking Opportunities
Ben Graham
ben.graham@ft.com
Sponsorship Opportunities
Rachel Joy
rachel.joy@ft.com
Delegate Services
Joshua Goddard
joshua.goddard@ft.com
Join our mailing list
Stay up to date with the latest news, events and offers from FT Live.